Patents by Inventor Sen-Yung Hsieh

Sen-Yung Hsieh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition and uses thereof
    Patent number: 9901594
    Abstract: Pharmaceutical compositions containing a combination of NPM inhibitor and anti-cancer agent are disclosed. Methods of inhibiting or reducing the growth of cancer cells in a subject, by administering an effective amount of nucleophosmin (NPM) inhibitor and one or more anti-cancer agents, whereby the symptoms and signs of cancer in the subject are reduced are also provided.
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: February 27, 2018
    Assignees: CHANG GUNG MEMORIAL HOSPITAL
    Inventor: Sen-yung Hsieh
  • NOVEL PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20170136053
    Abstract: Pharmaceutical compositions containing a combination of NPM inhibitor and anti-cancer agent are disclosed. Methods of inhibiting or reducing the growth of cancer cells in a subject, by administering an effective amount of nucleophosmin (NPM) inhibitor and one or more anti-cancer agents, whereby the symptoms and signs of cancer in the subject are reduced are also provided.
    Type: Application
    Filed: January 19, 2017
    Publication date: May 18, 2017
    Inventor: Sen-yung HSIEH
  • Pharmaceutical composition and uses thereof
    Patent number: 9592407
    Abstract: Pharmaceutical compositions containing a combination of NPM inhibitor and anti-cancer agent are disclosed. Methods of inhibiting or reducing the growth of cancer cells in a subject, by administering an effective amount of nucleophosmin (NPM) inhibitor and one or more anticancer agents, whereby the symptoms and signs of cancer in the subject are reduced are also provided.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: March 14, 2017
    Assignees: CHANG GUNG MEMORIAL HOSPITAL, LINKOU & HSIEH, THOMAS
    Inventor: Sen-yung Hsieh
  • NOVEL PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20150224334
    Abstract: Pharmaceutical compositions containing a combination of NPM inhibitor and anti-cancer agent are disclosed. Methods of inhibiting or reducing the growth of cancer cells in a subject, by administering an effective amount of nucleophosmin (NPM) inhibitor and one or more anticancer agents, whereby the symptoms and signs of cancer in the subject are reduced are also provided.
    Type: Application
    Filed: September 13, 2013
    Publication date: August 13, 2015
    Inventor: Sen-yung Hsieh
  • Protein markers for detecting liver cancer and method for identifying the markers thereof
    Patent number: 8741288
    Abstract: The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.
    Type: Grant
    Filed: July 7, 2010
    Date of Patent: June 3, 2014
    Assignee: Chang Gung Medical Foundation, Linkou Branch
    Inventor: Sen-Yung Hsieh
  • PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF
    Publication number: 20120225439
    Abstract: The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 6, 2012
    Applicant: CHANG GUNG MEDICAL FOUNDATION, LINKOU BRANCH
    Inventor: Sen-Yung Hsieh
  • PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF
    Publication number: 20120225795
    Abstract: The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 6, 2012
    Applicant: CHANG GUNG MEDICAL FOUNDATION, LINKOU BRANCH
    Inventor: Sen-Yung Hsieh
  • PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF
    Publication number: 20120225441
    Abstract: The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 6, 2012
    Applicant: CHANG GUNG MEDICAL FOUNDATION, LINKOU BRANCH
    Inventor: Sen-Yung Hsieh
  • PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF
    Publication number: 20120009596
    Abstract: The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.
    Type: Application
    Filed: July 7, 2010
    Publication date: January 12, 2012
    Inventor: Sen-Yung Hsieh